Journal•ISSN: 0975-8453
Systematic Reviews in Pharmacy
Medknow
About: Systematic Reviews in Pharmacy is an academic journal. The journal publishes majorly in the area(s): Population & Medicine. It has an ISSN identifier of 0975-8453. Over the lifetime, 1873 publications have been published receiving 5880 citations.
Papers
More filters
••
TL;DR: Nanoemulsions are submicron sized emulsions that are under extensive investigation as drug carriers for improving the delivery of therapeutic agents and show great promise for the future of cosmetics, diagnostics, drug therapies, and biotechnologies.
Abstract: Nanoemulsions are submicron sized emulsions that are under extensive investigation as drug carriers for improving the delivery of therapeutic agents. They are by far the most advanced nanoparticle systems for the systemic delivery of biologically active agents for controlled drug delivery and targeting. Nanoemulsions are the thermodynamically stable isotropic system in which two immiscible liquid (water and oil) are mixed to form a single phase by means of an appropriate surfactants or its mix with a droplet diameter approximately in the range of 0.5-100 um. Nanoemulsion droplet sizes fall typically in the range of 20-200 nm and show narrow size distributions. Nanoemulsion show great promise for the future of cosmetics, diagnostics, drug therapies, and biotechnologies. In this review, the attention is focused to give brief regarding nanoemulsion formulation aspect, method of preparation, characterization techniques with special emphasis on various applications of nanoemulsion in different areas such as in cancer treatment, in drug targeting, as a mucosal vaccine, as a vehicle for transdermal drug delivery and lipophilic drug, as a self-nanoemulsifying and solid self-nanoemulsifying drug delivery system, etc.
How to Cite this Article
Pubmed Style
Javed Ali, Pramod K, SH Ansari. Near-Infrared Spectroscopy for Nondestructive Evaluation of Tablets. SRP. 2010; 1(1): 17-23. doi:10.4103/0975-8453.59508
Web Style
Javed Ali, Pramod K, SH Ansari. Near-Infrared Spectroscopy for Nondestructive Evaluation of Tablets. http://www.sysrevpharm.org/?mno=302644626 [Access: March 28, 2021]. doi:10.4103/0975-8453.59508
AMA (American Medical Association) Style
Javed Ali, Pramod K, SH Ansari. Near-Infrared Spectroscopy for Nondestructive Evaluation of Tablets. SRP. 2010; 1(1): 17-23. doi:10.4103/0975-8453.59508
Vancouver/ICMJE Style
Javed Ali, Pramod K, SH Ansari. Near-Infrared Spectroscopy for Nondestructive Evaluation of Tablets. SRP. (2010), [cited March 28, 2021]; 1(1): 17-23. doi:10.4103/0975-8453.59508
Harvard Style
Javed Ali, Pramod K, SH Ansari (2010) Near-Infrared Spectroscopy for Nondestructive Evaluation of Tablets. SRP, 1 (1), 17-23. doi:10.4103/0975-8453.59508
Turabian Style
Javed Ali, Pramod K, SH Ansari. 2010. Near-Infrared Spectroscopy for Nondestructive Evaluation of Tablets. Systematic Reviews in Pharmacy, 1 (1), 17-23. doi:10.4103/0975-8453.59508
Chicago Style
Javed Ali, Pramod K, SH Ansari. "Near-Infrared Spectroscopy for Nondestructive Evaluation of Tablets." Systematic Reviews in Pharmacy 1 (2010), 17-23. doi:10.4103/0975-8453.59508
MLA (The Modern Language Association) Style
Javed Ali, Pramod K, SH Ansari. "Near-Infrared Spectroscopy for Nondestructive Evaluation of Tablets." Systematic Reviews in Pharmacy 1.1 (2010), 17-23. Print. doi:10.4103/0975-8453.59508
APA (American Psychological Association) Style
Javed Ali, Pramod K, SH Ansari (2010) Near-Infrared Spectroscopy for Nondestructive Evaluation of Tablets. Systematic Reviews in Pharmacy, 1 (1), 17-23. doi:10.4103/0975-8453.59508
285 citations
••
TL;DR: This paper is an attempt to summarise comparative aspects like definition, theories, types, methods of preparations, advantages, disadvantages and methods of analysis of emulsion, micro- emulsion and nano-emulsion.
Abstract: Lipid dosage forms are attractive delivery systems for hydrophobic drug molecules. Emulsion is one of the popular system since many decades. Pharmaceutical applications of emulsions widened especially after micro and nano-emulsion emergence. This paper is an attempt to summarise comparative aspects like definition, theories, types, methods of prepara-tions, advantages, disadvantages and methods of analysis of emulsion, micro-emulsion and nano-emulsion.
How to Cite this Article
Pubmed Style
Santosh Nemichand Kale,Sharada Laxman Deore. Emulsion Micro Emulsion and Nano Emulsion: A Review. SRP. 2017; 8(1): 39-47. doi:10.5530/srp.2017.1.8
Web Style
Santosh Nemichand Kale,Sharada Laxman Deore. Emulsion Micro Emulsion and Nano Emulsion: A Review. http://www.sysrevpharm.org/?mno=302644562 [Access: March 28, 2021]. doi:10.5530/srp.2017.1.8
AMA (American Medical Association) Style
Santosh Nemichand Kale,Sharada Laxman Deore. Emulsion Micro Emulsion and Nano Emulsion: A Review. SRP. 2017; 8(1): 39-47. doi:10.5530/srp.2017.1.8
Vancouver/ICMJE Style
Santosh Nemichand Kale,Sharada Laxman Deore. Emulsion Micro Emulsion and Nano Emulsion: A Review. SRP. (2017), [cited March 28, 2021]; 8(1): 39-47. doi:10.5530/srp.2017.1.8
Harvard Style
Santosh Nemichand Kale,Sharada Laxman Deore (2017) Emulsion Micro Emulsion and Nano Emulsion: A Review. SRP, 8 (1), 39-47. doi:10.5530/srp.2017.1.8
Turabian Style
Santosh Nemichand Kale,Sharada Laxman Deore. 2017. Emulsion Micro Emulsion and Nano Emulsion: A Review. Systematic Reviews in Pharmacy, 8 (1), 39-47. doi:10.5530/srp.2017.1.8
Chicago Style
Santosh Nemichand Kale,Sharada Laxman Deore. "Emulsion Micro Emulsion and Nano Emulsion: A Review." Systematic Reviews in Pharmacy 8 (2017), 39-47. doi:10.5530/srp.2017.1.8
MLA (The Modern Language Association) Style
Santosh Nemichand Kale,Sharada Laxman Deore. "Emulsion Micro Emulsion and Nano Emulsion: A Review." Systematic Reviews in Pharmacy 8.1 (2017), 39-47. Print. doi:10.5530/srp.2017.1.8
APA (American Psychological Association) Style
Santosh Nemichand Kale,Sharada Laxman Deore (2017) Emulsion Micro Emulsion and Nano Emulsion: A Review. Systematic Reviews in Pharmacy, 8 (1), 39-47. doi:10.5530/srp.2017.1.8
274 citations
••
TL;DR: The review article provides the information about the condition of the world before the implementation of PEPFAR program, history and political framework of the organisation, the goals of PepFAR, the funding sources and its partnership with different countries including India.
Abstract: Due to lack of facilities and expensive medicines most of the patients in developing courtiers do not get adequate treatment for HIV/AIDS. Hence it was an immediate requirement that the developed countries and the developing countries walk hand in hand on the path of defeating this epi-demic monster. President’s Emergency Plan for AIDS Relief is the largest global health initiative dedicated for the cure of a single disease by United States Government. The review article provides the information about the condition of the world before the implementation of PEPFAR program, his-tory and political framework of the organisation, the goals of PEPFAR, the funding sources and its partnership with different countries including India
How to Cite this Article
Pubmed Style
Jadeja S, Pai G, Bhat K, Sathyanarayana MB. President’s Emergency Plan for AIDS Relief. SRP. 2018; 9(1): 6-9. doi:10.5530/srp.2018.1.2
Web Style
Jadeja S, Pai G, Bhat K, Sathyanarayana MB. President’s Emergency Plan for AIDS Relief. http://www.sysrevpharm.org/?mno=302644540 [Access: March 28, 2021]. doi:10.5530/srp.2018.1.2
AMA (American Medical Association) Style
Jadeja S, Pai G, Bhat K, Sathyanarayana MB. President’s Emergency Plan for AIDS Relief. SRP. 2018; 9(1): 6-9. doi:10.5530/srp.2018.1.2
Vancouver/ICMJE Style
Jadeja S, Pai G, Bhat K, Sathyanarayana MB. President’s Emergency Plan for AIDS Relief. SRP. (2018), [cited March 28, 2021]; 9(1): 6-9. doi:10.5530/srp.2018.1.2
Harvard Style
Jadeja, S., Pai, . G., Bhat, . K. & Sathyanarayana, . M. B. (2018) President’s Emergency Plan for AIDS Relief. SRP, 9 (1), 6-9. doi:10.5530/srp.2018.1.2
Turabian Style
Jadeja, Siddharth, Girish Pai, Krishnamurthy Bhat, and Muddukrishna Badamane Sathyanarayana. 2018. President’s Emergency Plan for AIDS Relief. Systematic Reviews in Pharmacy, 9 (1), 6-9. doi:10.5530/srp.2018.1.2
Chicago Style
Jadeja, Siddharth, Girish Pai, Krishnamurthy Bhat, and Muddukrishna Badamane Sathyanarayana. "President’s Emergency Plan for AIDS Relief." Systematic Reviews in Pharmacy 9 (2018), 6-9. doi:10.5530/srp.2018.1.2
MLA (The Modern Language Association) Style
Jadeja, Siddharth, Girish Pai, Krishnamurthy Bhat, and Muddukrishna Badamane Sathyanarayana. "President’s Emergency Plan for AIDS Relief." Systematic Reviews in Pharmacy 9.1 (2018), 6-9. Print. doi:10.5530/srp.2018.1.2
APA (American Psychological Association) Style
Jadeja, S., Pai, . G., Bhat, . K. & Sathyanarayana, . M. B. (2018) President’s Emergency Plan for AIDS Relief. Systematic Reviews in Pharmacy, 9 (1), 6-9. doi:10.5530/srp.2018.1.2
234 citations
••
TL;DR: These studies provide insight into the mechanism of action of lupeol and suggest that it is a multi-target agent with immense anti-inflammatory potential targeting key molecular pathways which involve nuclear factor kappa B, cFLIP, Fas, Kras, phosphatidylinositol-3-kinase in a variety of cells.
Abstract: Pentacyclic lupane-type triterpenes, exemplified by lupeol [lup-20(29)-en-3b-ol], principally found in common fruit plants such as olive, mango, strawberry, grapes, etc., were reported to possess beneficial effects as a therapeutic and preventive agent for a range of disorders. Although lupeol exhibits an array of biological activities like anti-inflammatory and anti-arthritic activities both in in vitro and in vivo systems, extensive exploration to establish its role as a chemopreventive compound is warranted. Last 15 years have seen tremendous efforts by researchers worldwide to develop this wonderful molecule for its clinical use toward the treatment of a variety of disorders. These studies also provide insight into the mechanism of action of lupeol and suggest that it is a multi-target agent with immense anti-inflammatory potential targeting key molecular pathways which involve nuclear factor kappa B (NF-jB), cFLIP, Fas, Kras, phosphatidylinositol-3-kinase in a variety of cells. It is noteworthy that lupeol at its effective therapeutic doses exhibits no toxicity to normal cells and tissues. The perception of chemoprevention lies still in its infancy. Intervention to slow down, arrest or reverse the process of carcinogenesis by the use of either natural or synthetic substances individually or in combination therapy has emerged as a promising and pragmatic medical approach to reduce cancer risk.
190 citations
••
TL;DR: The article sheds light on the possible new criteria and class boundaries proposed for additional biowaivers based on the underlying physiology of the gastrointestinal tract in required cases.
Abstract: Biopharmaceutics Classification System (BCS) has provided a mechanistic framework for understanding the concept of drug absorption in terms of permeability and solubility. This article reviews the criteria and issues for classifying drugs according to the BCS. Biowaiver extensions for drug or active pharmaceutical ingredient from different BCS classes with scientific basis are discussed as the current BCS guidelines by World Health Organization, Unites State Food and Drug Administration and European Medicines Agency allows for biowaivers based on conservative criteria. The article sheds light on the possible new criteria and class boundaries proposed for additional biowaivers based on the underlying physiology of the gastrointestinal tract in required cases. The potential applications of BCS in drug discovery, drug delivery and drug research as well as extension for BCS are discussed.
How to Cite this Article
Pubmed Style
Chavda HV, Patel CN, Anand IS. Biopharmaceutics Classification System. SRP. 2010; 1(1): 62-69. doi:10.4103/0975-8453.59514
Web Style
Chavda HV, Patel CN, Anand IS. Biopharmaceutics Classification System. http://www.sysrevpharm.org/?mno=302644632 [Access: March 28, 2021]. doi:10.4103/0975-8453.59514
AMA (American Medical Association) Style
Chavda HV, Patel CN, Anand IS. Biopharmaceutics Classification System. SRP. 2010; 1(1): 62-69. doi:10.4103/0975-8453.59514
Vancouver/ICMJE Style
Chavda HV, Patel CN, Anand IS. Biopharmaceutics Classification System. SRP. (2010), [cited March 28, 2021]; 1(1): 62-69. doi:10.4103/0975-8453.59514
Harvard Style
Chavda HV, Patel CN, Anand IS (2010) Biopharmaceutics Classification System. SRP, 1 (1), 62-69. doi:10.4103/0975-8453.59514
Turabian Style
Chavda HV, Patel CN, Anand IS. 2010. Biopharmaceutics Classification System. Systematic Reviews in Pharmacy, 1 (1), 62-69. doi:10.4103/0975-8453.59514
Chicago Style
Chavda HV, Patel CN, Anand IS. "Biopharmaceutics Classification System." Systematic Reviews in Pharmacy 1 (2010), 62-69. doi:10.4103/0975-8453.59514
MLA (The Modern Language Association) Style
Chavda HV, Patel CN, Anand IS. "Biopharmaceutics Classification System." Systematic Reviews in Pharmacy 1.1 (2010), 62-69. Print. doi:10.4103/0975-8453.59514
APA (American Psychological Association) Style
Chavda HV, Patel CN, Anand IS (2010) Biopharmaceutics Classification System. Systematic Reviews in Pharmacy, 1 (1), 62-69. doi:10.4103/0975-8453.59514
89 citations